Cargando…

The risk and clinical outcome of candidemia depending on underlying malignancy

PURPOSE: To assess the risk factors and outcomes associated with fungemia caused by the six most commonly occurring Candida species in patients with and without malignancies. METHODS: Analysis of the episodes of fungemia due to common Candida species in adults, based on an active hospital-based surv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lortholary, Olivier, Renaudat, Charlotte, Sitbon, Karine, Desnos-Ollivier, Marie, Bretagne, Stéphane, Dromer, Françoise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Original
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384959/ https://www.ncbi.nlm.nih.gov/pubmed/28321466 http://dx.doi.org/10.1007/s00134-017-4743-y

Ejemplares similares

Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002–2010)
por: Lortholary, Olivier, et al.
Publicado: (2014)

No Impact of Fluconazole to Echinocandins Replacement as First-Line Therapy on the Epidemiology of Yeast Fungemia (Hospital-Driven Active Surveillance, 2004–2017, Paris, France)
por: Bretagne, Stéphane, et al.
Publicado: (2021)

P253 Features of Cryptococcosis in human immunodeficiency virus-negative patients, France 1985-2020
por: Paccoud, Olivier, et al.
Publicado: (2022)

Candida spp. with Acquired Echinocandin Resistance, France, 2004–2010
por: Dannaoui, Eric, et al.
Publicado: (2012)

Dynamics of Cryptococcus neoformans-Macrophage Interactions Reveal that Fungal Background Influences Outcome during Cryptococcal Meningoencephalitis in Humans
por: Alanio, Alexandre, et al.
Publicado: (2011)

Clonal Population of Flucytosine-Resistant Candida tropicalis from Blood Cultures, Paris, France
por: Desnos-Ollivier, Marie, et al.
Publicado: (2008)

Cryptococcosis Serotypes Impact Outcome and Provide Evidence of Cryptococcus neoformans Speciation
por: Desnos-Ollivier, Marie, et al.
Publicado: (2015)

Ten-Year Experience of Cutaneous and/or Subcutaneous Infections Due to Coelomycetes in France
por: Guégan, Sarah, et al.
Publicado: (2016)

Cutaneous Invasive Aspergillosis: Retrospective Multicenter Study of the French Invasive-Aspergillosis Registry and Literature Review
por: Bernardeschi, Céline, et al.
Publicado: (2015)

Candida haemulonii complex, an emerging threat from tropical regions?
por: Françoise, Ugo, et al.
Publicado: (2023)

Antifungal Susceptibility Profiles of 1698 Yeast Reference Strains Revealing Potential Emerging Human Pathogens
por: Desnos-Ollivier, Marie, et al.
Publicado: (2012)

Recurrent episodes of Candidemia due to Candida glabrata, Candida tropicalis and Candida albicans with acquired echinocandin resistance
por: Grosset, Marine, et al.
Publicado: (2016)

Genetic Diversity and Genomic Plasticity of Cryptococcus neoformans AD Hybrid Strains
por: Li, Wenjun, et al.
Publicado: (2012)

Determinants of Disease Presentation and Outcome during Cryptococcosis: The CryptoA/D Study
por: Dromer, Françoise, et al.
Publicado: (2007)

Active Surveillance Program to Increase Awareness on Invasive Fungal Diseases: the French RESSIF Network (2012 to 2018)
por: Bretagne, Stéphane, et al.
Publicado: (2022)

Cryptococcus gattii in Patients with Lymphoid Neoplasms: An Illustration of Evolutive Host–Fungus Interactions
por: Paccoud, Olivier, et al.
Publicado: (2021)

Saprochaete clavata Outbreak Infecting Cancer Center through Dishwasher
por: Menu, Estelle, et al.
Publicado: (2020)

Mixed Infections and In Vivo Evolution in the Human Fungal Pathogen Cryptococcus neoformans
por: Desnos-Ollivier, Marie, et al.
Publicado: (2010)

Major Role for Amphotericin B–Flucytosine Combination in Severe Cryptococcosis
por: Dromer, Françoise, et al.
Publicado: (2008)

Comparison of MultiLocus Sequence Typing (MLST) and Microsatellite Length Polymorphism (MLP) for Pneumocystis jirovecii genotyping
por: Gits-Muselli, Maud, et al.
Publicado: (2020)

Comparison of albicans vs. non-albicans candidemia in French intensive care units
por: Leroy, Olivier, et al.
Publicado: (2010)

Diversity of Pneumocystis jirovecii during Infection Revealed by Ultra-Deep Pyrosequencing
por: Alanio, Alexandre, et al.
Publicado: (2016)

Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal
por: Loyse, Angela, et al.
Publicado: (2013)

Candidemia before and after the COVID-19 pandemic: An analysis of risk factors and outcomes in patients with candidemia
por: Colburn, Nora, et al.
Publicado: (2022)

Risk factors and outcomes of patients with ocular involvement of candidemia
por: Son, Hyo-Ju, et al.
Publicado: (2019)

Fluconazole and Echinocandin Resistance of Candida glabrata Correlates Better with Antifungal Drug Exposure Rather than with MSH2 Mutator Genotype in a French Cohort of Patients Harboring Low Rates of Resistance
por: Dellière, Sarah, et al.
Publicado: (2016)

Impact of select risk factors on treatment outcome in adults with candidemia
por: Hill, Brandon, et al.
Publicado: (2019)

Cryptococcal Neuroradiological Lesions Correlate with Severity during Cryptococcal Meningoencephalitis in HIV-Positive Patients in the HAART Era
por: Charlier, Caroline, et al.
Publicado: (2008)

Population-Based Analysis of Invasive Fungal Infections, France, 2001–2010
por: Bitar, Dounia, et al.
Publicado: (2014)

Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B
por: Dupont, Bertrand F, et al.
Publicado: (2009)

Increasing Incidence of Zygomycosis (Mucormycosis), France, 1997–2006
por: Bitar, Dounia, et al.
Publicado: (2009)

Risk Factors and Outcomes of Recurrent Candidemia in Children: Relapse or Re-Infection?
por: Lai, Mei-Yin, et al.
Publicado: (2019)

Risk Factors and Clinical Outcomes of Candidemia Associated With Severe COVID-19
por: Dixit, Deepali, et al.
Publicado: (2022)

Effect of Statin Use on Outcomes of Adults with Candidemia
por: Cuervo, Guillermo, et al.
Publicado: (2013)

367. Influence of Body Weight and Outcomes in Candidemia
por: Musgrove, Mary, et al.
Publicado: (2018)

1722. The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Emerging Risk Factor for Candidemia
por: Zhang, Alexia Y, et al.
Publicado: (2018)

Literature Review and Case Histories of Histoplasma capsulatum var. duboisii Infections in HIV-infected Patients
por: Loulergue, Pierre, et al.
Publicado: (2007)

Risk Factors for Mortality in Colombian Patients with Candidemia
por: Cortés, Jorge Alberto, et al.
Publicado: (2021)

Candida glabrata candidemia
por: Chakrabarti, Arunaloke
Publicado: (2015)

Candidemia en Colombia
por: Cortés, Jorge Alberto, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eitnceffus4j73rgb2rolrq1la